| Sign In to gain access to subscriptions and/or personal tools. |
Bolesatine induces agglutination of rat platelets and human erythrocytes and platelets in vitroINSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Centre Régional de Transfusion Sanguine, 10 rue Spielmann, 67085 Strasbourg CEDEX
Laboratoire de Toxicologie et d'Hygiène Appliquée, Université de Bordeaux 2, 3ter place de la Victoire, 33000 Bordeaux
Laboratoire de Toxicologie et d'Hygiène Appliquée, Université de Bordeaux 2, 3ter place de la Victoire, 33000 Bordeaux
INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Centre Régional de Transfusion Sanguine, 10 rue Spielmann, 67085 Strasbourg CEDEX
INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Centre Régional de Transfusion Sanguine, 10 rue Spielmann, 67085 Strasbourg CEDEX
Laboratoire de Toxicologie et d'Hygiène Appliquée, Université de Bordeaux 2, 3ter place de la Victoire, 33000 Bordeaux
Institut de Biologie Moléculaire et Cellulaire du CNRS and Université Louis Pasteur, 15 rue Descartes, 67084 Strasbourg CEDEX, France
INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Centre Régional de Transfusion Sanguine, 10 rue Spielmann, 67085 Strasbourg CEDEX Bolesatine is a toxic glycoprotein isolated from the mushroom Boletus satanas Lenz, which has been shown to inhibit protein synthesis in cell-free systems and cell culture. It is toxic to rodents, the LD50% 24 h being 1 mg kg-1 (i.p.) and 0.15 mg kg-1 (i.v) in the rat in which it induces hepatic blood stasis. Bolesatine possesses lectinic properties with in parti cular a sugar binding site for D-galactose and mitogenic activity toward lymphocytes. Tested for cell agglutination on red blood cells and platelets, bolesatine agglutinates both human and rat platelets from threshold concentrations of 30 and 300 nM respectively. EDTA and PGI2 (aggregation inhibitors) do not decrease the agglutination induced by bolesatine, indicating that the process does not involve platelet activation. In contrast, fibrinogen decreases platelet agglutination in duced by bolesatine, most likely by masking the binding sites on platelets or by interacting with the toxin. Bolesatine agglutinates all red blood cells without any blood group specificity in the concentration range of 20 to 40 nM. This haemagglutination cannot be prevented by sugars, including D-galactose at a concentration of 0.5 M.
Key Words: Bolesatine Boletus satanas agglutination aggrega tion rat man
Human & Experimental Toxicology, Vol. 15, No. 1,
26-29 (1996) |
|||